Drug intelligence / Profile preview

gramicidin S

Development stage
Phase 1
Lead developer
Ministry of Health of the USSR
Modality
Peptides
Administration
Topical
01

Overview

**Gramicidin S** is a cationic cyclic decapeptide antibiotic produced by *Aneurinibacillus migulanus* and composed of two repeating pentapeptide units. It acts through broad, non-receptor-mediated interaction with microbial phospholipid membranes, causing membrane destabilization, increased permeability, leakage of cellular contents, and microbial cell death. Its membrane activity also creates hemolytic and cytotoxic liabilities that limit use primarily to local topical applications. Gramicidin S is an active ingredient in certain Valenta Pharm Grammidin topical spray products for infectious and inflammatory throat conditions, where it is co-formulated with cetylpyridinium chloride; that combination product should not be conflated with gramicidin S as a single active substance. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11354511/))

Brand names
GrammidinGrammidin NeoGrammidin with Anesthetic
Other names
gramicidin Soviet
02

Targets

Lipid ARNAP (Bacterial dna-dependent RNA polymerase)

Beyond the preview

Go deeper on gramicidin S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gramicidin S.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call